Our Products
Our core business lies in the development, production and distribution of high-quality, affordable generic medicines. We offer approximately 1 100 generic compounds worldwide and are a leading provider of differentiated, value-added products, including state-of-the-art biosimilars, injectables, inhalers and transdermal patches.
Therapeutic Areas
Our portfolio of medicines includes both blockbusters and niche products for all major therapeutic areas.
Product Forms
At Sandoz, we differentiate ourselves through our broad range of product forms and ability to develop and produce complex, value-added generic products.
Related content
Pioneering Biosimilars
Sandoz is the pioneer and undisputed global leader in the rapidly emerging market for biosimilars.
